Literature DB >> 15816520

Role of p21WAF1 in green tea polyphenol-induced growth arrest and apoptosis of oral carcinoma cells.

Stephen Hsu1, Kajuana Farrey, John Wataha, Jill Lewis, James Borke, Baldev Singh, Haiyan Qin, Carol Lapp, David Lapp, Tuan Nguyen, George Schuster.   

Abstract

The cyclin-dependent kinase inhibitor p21WAF1 participates in cell growth, differentiation, and apoptosis. p21WAF1 can be induced by green tea polyphenol EGCG in several cancer cell types, but its role in the oral cancer cell response to EGCG is not known. We found that EGCG upregulates p21WAF1 in an oral carcinoma cell line, OSC2, by cDNA microarray. The current study determined the impact of siRNA-suppressed p21WAF1 and its response to EGCG on cell growth, DNA synthesis and apoptosis by RT-PCR, Western blot, BrdU incorporation, MTT and caspase 3 activity assays. Suppression of p21WAF1 by siRNA resulted in an accelerated cell growth and DNA synthesis, and increased cell viability. However, caspase 3 activity was not significantly inhibited. The evidence showed that p21WAF1 is involved in EGCG-induced growth arrest of OSC2 cells, which may facilitate caspase 3-mediated apoptosis. Thus, expression of functional p21WAF1 may promote phytochemical-mediated growth arrest and apoptosis in oral carcinoma cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15816520

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  9 in total

1.  Green tea polyphenols and metabolites in prostatectomy tissue: implications for cancer prevention.

Authors:  Piwen Wang; William J Aronson; Min Huang; Yanjun Zhang; Ru-Po Lee; David Heber; Susanne M Henning
Journal:  Cancer Prev Res (Phila)       Date:  2010-07-13

2.  Growth inhibition and apoptosis by (-)-epicatechin gallate are mediated by cyclin D1 suppression in head and neck squamous carcinoma cells.

Authors:  Young Chang Lim; Seong-Ho Lee; Mee Hyun Song; Kiyoshi Yamaguchi; Joo-Heon Yoon; Eun Chang Choi; Seung Joon Baek
Journal:  Eur J Cancer       Date:  2006-10-12       Impact factor: 9.162

3.  Phase 2 randomized study of p53 antisense oligonucleotide (cenersen) plus idarubicin with or without cytarabine in refractory and relapsed acute myeloid leukemia.

Authors:  Jorge Cortes; Hagop Kantarjian; Edward D Ball; John Dipersio; Jonathan E Kolitz; Hugo F Fernandez; Mark Goodman; Gautam Borthakur; Maria R Baer; Meir Wetzler
Journal:  Cancer       Date:  2011-06-29       Impact factor: 6.860

4.  Epigallocatechin-3-gallate prevents autoimmune-associated down- regulation of p21 in salivary gland cells through a p53-independent pathway.

Authors:  Douglas Dickinson; Hongfang Yu; Seiji Ohno; Cristina Thomas; Scott Derossi; Yat-Ho Ma; Nicole Yates; Emily Hahn; Frederick Bisch; Tetsuya Yamamoto; Stephen Hsu
Journal:  Inflamm Allergy Drug Targets       Date:  2014-02

5.  Dentin sialophosphoprotein (DSPP) gene-silencing inhibits key tumorigenic activities in human oral cancer cell line, OSC2.

Authors:  Rajeshree Joshi; Amany Tawfik; Nneka Edeh; Veronica McCloud; Stephen Looney; Jill Lewis; Stephen Hsu; Kalu U E Ogbureke
Journal:  PLoS One       Date:  2010-11-12       Impact factor: 3.240

6.  The chemopreventive properties and therapeutic modulation of green tea polyphenols in oral squamous cell carcinoma.

Authors:  Ui-Lyong Lee; Sung-Weon Choi
Journal:  ISRN Oncol       Date:  2011-05-16

Review 7.  Chemopreventive role of green tea in head and neck cancers.

Authors:  Yoo Suk Kim; Chul-Ho Kim
Journal:  Integr Med Res       Date:  2013-12-17

8.  The cytotoxic mechanism of epigallocatechin gallate on proliferative HaCaT keratinocytes.

Authors:  Yu-Wen Chu; Shu-Ting Liu; Ya-Lan Yang; Shih-Ming Huang; Wei-Ming Wang
Journal:  J Biomed Sci       Date:  2017-08-15       Impact factor: 8.410

Review 9.  Protection of dietary polyphenols against oral cancer.

Authors:  Yijian Ding; Hua Yao; Yanan Yao; Leonard Yenwong Fai; Zhuo Zhang
Journal:  Nutrients       Date:  2013-06-14       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.